Author: Ian Conway
Ian Conway has worked in financial markets for over 30 years as a bond and equity trader, Extel-rated analyst and strategist, and partner of a stockbroking firm. He also founded a financial research company servicing institutional clients prior to writing for and editing Shares magazine. Ian is primarily an income investor although he also buys selected growth stocks. Find him at LinkedIn: Click Here
Shares in custom electronics maker DiscoverIE (LON:DSCV) rallied after the company raised its FY27 outlook. The firm said the strong momentum of Q4 had continued into Q1 with sales and order increasing more than expected. Strong sales and orders The Surrey-based group serves the health care, security, power, energy transformation and renewables sectors. Its products range from X-ray detectors used in hospitals and airport scanners to battery energy storage, electric motors and isolator switches. Sales for the three months to June were up 6% on an underlying basis and 10% including recent acquisitions Storm and Trival. Both businesses are ‘performing…
Shares in specialist engineering firm Renishaw (LON:RSW) jumped after the company raised its FY26 sales and profit guidance. In its trading update for the quarter to in June, the firm said it had seen ‘accelerating growth’ throughout the year. Growth accelerating Renishaw is a leading supplier of measuring and production systems, which offer a high degree of accuracy and precision in manufactirung. In its H1 update, the firm said it had seen growth accelerate across its divisions and an increase in its operating margin despite currency headwinds. The firm also reported ‘significant’ progress in its emerging businesses, and introduced new…
Infrastructure, construction and fit-out group Morgan Sindall (LON:MGNS) reported another record half-year for the six months to June. Excluding Covid, the firm has posted record H1 results for 11 years running, and given the strong fundamentals for Construction and Fit-Out it has now increased its medium-term targets for both businesses. Record H1 results The company posted an 8% increase in H1 revenue to £2.56 billion and a 21% increase in adjusted pre-tax profit to £116 million, beating analysts’ forecasts. Thanks to this strong profit growth, the adjusted pre-tax margin rose to 4.5% from 4% a year earlier. Construction revenue grew…
Shares in pub group JD Wetherspoon (LON:JDW) dropped 8% after chairman Tim Martin confirmed FY earnings were likely to miss forecasts. Martin blamed lower-than-expected Q4 sales and higher costs across food, labour, repairs, energy and business rates. Below expectations In a trading update covering the 12 weeks to 19 July, the firm said like-for-like sales rose 4%. That was marginally behind the 4.3% increase of the first nine months and took the annual growth rate to 4.2%. As a result, FY profit is likely to be below market expectations, said Martin. According to Stockopedia, the consensus forecasts for FY 26…
Shares in AIM-listed semiconductor products firm IQE (LON:IQE) jumped 10% after it increased its FY sales forecast on strong demand. Revenue is now expected to grow by 30% to around £130 million against a previous forecast of a 20% increase. Sales top forecasts on insatiable AI demand The firm said H1 trading had exceeded forecasts, with sales now expected to hit at least £64 million. Demand for its InP (Indium Phosphate) solutions in particular is accelerating due to their critical role in enabling optical photonics products for data centres and AI infrastructure. Growth was also supported by aerospace and defence…
Facilities management firm Mitie Group (LON:MTO) has agreed a £3.1 billion cash takeover proposal from UK peer OCS. The deal values MITIE shares at 221.6p, including a 3.1p final dividend for FY26, or a 47% premium to last night’s close. Delivering value for shareholders Bringing together OCS and Mitie would create one of the largest private-sector UK firms with around £8.5 billion in annual revenue. It would also consolidate OCS’s position in managing government, defence, healthcare and infrastructure facilities. Mitie CEO Phil Bentley called the deal ‘a testament to everything we have achieved in recent years. This recommended offer reflects…
UK self-storage operator Big Yellow Group (LON:BYG) posted a 2% increase in Q1 like-for-like revenue, continuing the trend FY25/26 trend. Like-for-like occupancy in the quarter to June dipped 0.2%, while average rent per square foot rose 3%. Pipeline growth Occupancy across the group’s 113 stores increased by 161,000 square feet or 2.4% of the maximum lettable area at 30 June. That compared with a 47,000 square foot or 0.5% increase at the same point last year. While like-for-like occupancy dipped 0.2% to 79.2%, the average rate increased 3% to £36.68 per square foot. Group revenue for the quarter was up…
Warehouse and data centre operator SEGRO (LON:SGRO) has turned down a third offer from Prologis (NYSE:PLD) valuing it at £13.5 billion. The US suitor insists its proposal represents ‘a compelling opportunity’ and has urged SEGRO shareholders to lobby the board. Third attempt The latest offer consists of 0.089 new Prologis shares with a partial cash alternative for 20% of the total consideration. Based on current share prices and the GBP/USD exchange rate, SEGRO shareholders would get roughly 993p per share. That’s a 3.4% premium to the initial Prologis offer, which was pitched at a 25% premium to SEGRO’s underlying price.…
Investment trust Biotech Growth (LON:BIOG) scored yet another win as US pharma giant Eli Lilly (NYSE:LLY) snapped up portfolio company AtaiBeckley (NASDAQ:ATAI). The deal represents another success for the trust ‘and further validates our investment strategy’ said manager Geoff Hsu. Eighth deal this year Eli Lilly announced it would buy AtaiBeckley for around $2.8 billion or $6.75/share, a 26% premium to its market value. Furthermore, the deal includes $1 billion in contingent value rights payments, taking the total price to $3.8 billion or $9.25/share. AtaiBeckley is a clinical-stage biotech company focused on the development of drugs for the treatment of…
The reporting pace cranks up next week as US reporting season goes through the gears, with results from Alphabet (NASDAQ:GOOG) and Tesla (NASDAQ:TSLA) set to dominate headlines alongside updates from UK companies including JD Wetherspoon (LON:JDW) and Wickes (LON:WIX). Alphabet’s earnings will be scrutinised for signs that its heavy AI investment is translating into stronger cloud growth and advertising revenue, while Tesla shareholders will be watching not only margins and vehicle demand but also any commentary on persistent speculation over closer ties with SpaceX (NASDAQ:SPCX). In the UK, investors will look to JD Wetherspoon and Wickes for fresh insight into…













